• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
COVID-19 vaccine response in patients with hematologic malignancy: A systematic review and meta-analysis.血液系统恶性肿瘤患者对COVID-19疫苗的反应：一项系统评价和荟萃分析。
Am J Hematol. 2022 Apr;97(4):E132-E135. doi: 10.1002/ajh.26459. Epub 2022 Jan 13.
2
Cellular response to COVID-19 vaccines in hematologic malignancies patients: a new hope for non-responders?血液系统恶性肿瘤患者对新冠疫苗的细胞反应：无反应者的新希望？
Leuk Lymphoma. 2022 Mar;63(3):743-746. doi: 10.1080/10428194.2021.1998485. Epub 2021 Oct 28.
3
COVID-19 in patients with hematologic malignancy.血液恶性肿瘤患者中的 COVID-19 感染。
Blood. 2022 Jul 21;140(3):236-252. doi: 10.1182/blood.2021012251.
4
SARS-CoV-2 Vaccine Efficacy in Patients with Hematologic Malignancies: Practical Points for Further Research.SARS-CoV-2 疫苗在血液系统恶性肿瘤患者中的疗效：进一步研究的实用要点。
Oncologist. 2022 Nov 3;27(11):e917-e918. doi: 10.1093/oncolo/oyac173.
5
Immunogenicity of COVID-19 vaccines in patients with hematologic malignancies: a systematic review and meta-analysis.COVID-19 疫苗在血液系统恶性肿瘤患者中的免疫原性：系统评价和荟萃分析。
Blood Adv. 2022 Apr 12;6(7):2014-2034. doi: 10.1182/bloodadvances.2021006333.
6
Antibody response to SARS-CoV-2 vaccines in patients with hematologic malignancies.血液系统恶性肿瘤患者对SARS-CoV-2疫苗的抗体反应。
Cancer Cell. 2021 Aug 9;39(8):1031-1033. doi: 10.1016/j.ccell.2021.07.012. Epub 2021 Jul 22.
7
Therapy in Patients with Hematologic Malignancies, Seroconversion Rates, and SARS-CoV-2 Vaccination.血液系统恶性肿瘤患者的治疗、血清转化率和 SARS-CoV-2 疫苗接种。
Oncologist. 2022 Nov 3;27(11):e916. doi: 10.1093/oncolo/oyac169.
8
COVID-19 vaccines for patients with haematological conditions.用于血液系统疾病患者的新冠疫苗。
Lancet Haematol. 2021 May;8(5):e312-e314. doi: 10.1016/S2352-3026(21)00073-9. Epub 2021 Mar 31.
9
Blunted humoral response after mRNA vaccine in patients with haematological malignancies.血液系统恶性肿瘤患者接种mRNA疫苗后体液免疫反应减弱。
Lancet Haematol. 2021 Aug;8(8):e540-e542. doi: 10.1016/S2352-3026(21)00197-6. Epub 2021 Jul 2.
10
Immunogenicity of the COVID-19 Two-Vaccination Series Among Hematologic Malignancies: Report of Three Cases of Breakthrough Infection.血液恶性肿瘤患者 COVID-19 两剂疫苗系列的免疫原性：三例突破性感染报告。
Cancer Control. 2022 Jan-Dec;29:10732748211070720. doi: 10.1177/10732748211070720.

引用本文的文献

1
Safety, Immunogenicity, and Efficacy of COVID-19 Vaccines in Radiation-Oncology Patients: A Systematic Review and Meta-Analysis.COVID-19疫苗在放射肿瘤学患者中的安全性、免疫原性和有效性：一项系统评价和荟萃分析
Vaccines (Basel). 2025 Jun 30;13(7):715. doi: 10.3390/vaccines13070715.
2
Immune response dynamics of SARS-CoV-2 vaccination in chronic lymphocytic leukemia individuals: a descriptive analysis.慢性淋巴细胞白血病患者中SARS-CoV-2疫苗接种的免疫反应动力学：一项描述性分析
Front Immunol. 2025 Jun 6;16:1571680. doi: 10.3389/fimmu.2025.1571680. eCollection 2025.
3
COVID-19 Vaccination in Patients with Hematological Malignances.血液系统恶性肿瘤患者的新冠病毒疫苗接种
Vaccines (Basel). 2025 Apr 25;13(5):465. doi: 10.3390/vaccines13050465.
4
Causes of death among patients diagnosed with chronic lymphocytic leukemia: A population-based study in the Netherlands, 1996-2020.1996 - 2020年荷兰一项基于人群的研究：慢性淋巴细胞白血病确诊患者的死因
Hemasphere. 2024 Nov 12;8(11):e70015. doi: 10.1002/hem3.70015. eCollection 2024 Nov.
5
Delphi Panel Consensus Statement Generation: COVID-19 Vaccination Recommendations for Immunocompromised Populations in the European Union.德尔菲专家小组共识声明生成：欧盟免疫功能低下人群的新冠疫苗接种建议
Infect Dis Ther. 2024 Nov;13(11):2227-2253. doi: 10.1007/s40121-024-01051-9. Epub 2024 Oct 9.
6
Outcomes of COVID-19 in patients with lymphomas participating in registered clinical trials: A real-world study from China in the Omicron outbreak era.奥密克戎变异株流行期中国真实世界研究：登记注册临床试验中淋巴瘤患者感染 COVID-19 的结局。
Cancer Med. 2023 Dec;12(23):21148-21158. doi: 10.1002/cam4.6678. Epub 2023 Nov 27.
7
COVID-19 in Patients with Chronic Lymphocytic Leukemia: What Have We Learned?慢性淋巴细胞白血病患者中的新冠病毒肺炎：我们了解到了什么？
Acta Haematol. 2024;147(1):60-72. doi: 10.1159/000534540. Epub 2023 Oct 11.
8
Infections in patients with chronic lymphocytic leukemia.慢性淋巴细胞白血病患者的感染
Hematol Transfus Cell Ther. 2023 Jul-Sep;45(3):387-393. doi: 10.1016/j.htct.2023.05.006. Epub 2023 Jul 1.
9
Outcomes of SARS-CoV-2 infection in Ph-neg chronic myeloproliferative neoplasms: results from the EPICOVIDEHA registry.Ph阴性慢性骨髓增殖性肿瘤患者感染新型冠状病毒2的结局：EPICOVIDEHA注册研究结果
Ther Adv Hematol. 2023 Mar 11;14:20406207231154706. doi: 10.1177/20406207231154706. eCollection 2023.
10
Association of COVID-19 Vaccination With Breakthrough Infections and Complications in Patients With Cancer.COVID-19 疫苗接种与癌症患者突破性感染和并发症的关联。
JAMA Oncol. 2023 Mar 1;9(3):386-394. doi: 10.1001/jamaoncol.2022.6815.

本文引用的文献

1
Anti-spike antibody response to SARS-CoV-2 booster vaccination in patients with B cell-derived hematologic malignancies.B细胞源性血液系统恶性肿瘤患者对SARS-CoV-2加强疫苗接种的抗刺突抗体反应
Cancer Cell. 2021 Oct 11;39(10):1297-1299. doi: 10.1016/j.ccell.2021.09.001. Epub 2021 Sep 7.
2
Antibody and T cell immune responses following mRNA COVID-19 vaccination in patients with cancer.癌症患者接种新冠病毒mRNA疫苗后的抗体和T细胞免疫反应。
Cancer Cell. 2021 Aug 9;39(8):1034-1036. doi: 10.1016/j.ccell.2021.07.016. Epub 2021 Jul 27.
3
Covid-19 Breakthrough Infections in Vaccinated Health Care Workers.新冠疫苗突破性感染在已接种疫苗的医护人员中发生。
N Engl J Med. 2021 Oct 14;385(16):1474-1484. doi: 10.1056/NEJMoa2109072. Epub 2021 Jul 28.
4
Association of Convalescent Plasma Therapy With Survival in Patients With Hematologic Cancers and COVID-19.恢复期血浆疗法与血液系统恶性肿瘤合并 COVID-19 患者生存情况的关联
JAMA Oncol. 2021 Jun 17;7(8):1167-75. doi: 10.1001/jamaoncol.2021.1799.
5
Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection.中和抗体水平高度预测对有症状的 SARS-CoV-2 感染的免疫保护作用。
Nat Med. 2021 Jul;27(7):1205-1211. doi: 10.1038/s41591-021-01377-8. Epub 2021 May 17.
6
B cell reconstitution after rituximab treatment of lymphoma recapitulates B cell ontogeny.利妥昔单抗治疗淋巴瘤后的B细胞重建重现了B细胞的个体发生过程。
Clin Immunol. 2007 Feb;122(2):139-45. doi: 10.1016/j.clim.2006.08.009. Epub 2006 Sep 27.

COVID-19 vaccine response in patients with hematologic malignancy: A systematic review and meta-analysis.

作者信息

Gong Inna Y, Vijenthira Abi, Betschel Stephen D, Hicks Lisa K, Cheung Matthew C

机构信息

Department of Medicine, University of Toronto, Toronto, Ontario, Canada.

Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.

出版信息

Am J Hematol. 2022 Apr;97(4):E132-E135. doi: 10.1002/ajh.26459. Epub 2022 Jan 13.

DOI:10.1002/ajh.26459
PMID:35007350
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9011569/
Abstract
摘要